115 related articles for article (PubMed ID: 3520306)
1. Mutagenicity of N-arylacetohydroxamic acids and their O-glucosides derived from chlorinated 4-nitrobiphenyl ethers.
Yoshioka T; Takou Y; Uematsu T
Mutat Res; 1986 Jun; 170(3):93-102. PubMed ID: 3520306
[TBL] [Abstract][Full Text] [Related]
2. Mutagenic activity of possible metabolites of 4-nitrobiphenyl ether.
Miyauchi M; Takou Y; Watanabe M; Uematsu T
Chem Biol Interact; 1984 Sep; 51(1):49-62. PubMed ID: 6378413
[TBL] [Abstract][Full Text] [Related]
3. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
Wesp HF; Tang X; Edenharder R
Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of chlorinated products from soil humic substances.
Sato T; Mukaida M; Ose Y; Nagase H; Ishikawa T
Sci Total Environ; 1985 Nov; 46():229-41. PubMed ID: 3909401
[TBL] [Abstract][Full Text] [Related]
5. Mutagenicity of derivatives and metabolites of 1-nitropyrene: activation by rat liver S9 and bacterial enzymes.
Ball LM; Kohan MJ; Claxton LD; Lewtas J
Mutat Res; 1984; 138(2-3):113-25. PubMed ID: 6392870
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of some derivatives of dipyrido[1,2-a:3',2'-d]imidazoles in Salmonella typhimurium with metabolic activation by rat liver and small intestine subcellular fractions.
N'Goy K; Saint-Ruf G; de Meester C
Mutat Res; 1985; 156(1-2):53-9. PubMed ID: 3889627
[TBL] [Abstract][Full Text] [Related]
7. Mutagenic activity of chlorinated 4-nitrobiphenyl ethers and their nitroso- and amino-derivatives.
Miyauchi M; Haga M; Takou Y; Uematsu T
Chem Biol Interact; 1983; 44(1-2):133-41. PubMed ID: 6342825
[No Abstract] [Full Text] [Related]
8. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
Suter W; Matter-Jaeger I
Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of amine drugs and their products of nitrosation.
Andrews AW; Lijinsky W; Snyder SW
Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
[TBL] [Abstract][Full Text] [Related]
11. Mutagenic activity of newly synthesized sulfa drugs to Salmonella typhimurium.
Temcharoen P; Nerapattanakid S; Toskulkao C; Glinsukon T; Paovaro C; Ruchirawat S
Mutat Res; 1994 Jun; 321(4):187-95. PubMed ID: 7515156
[TBL] [Abstract][Full Text] [Related]
12. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
[TBL] [Abstract][Full Text] [Related]
13. The mutagenic potential of 25 organophosphinate compounds.
Sauers LJ; Fruin JT
Mutat Res; 1982 Nov; 105(5):299-302. PubMed ID: 6755236
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the mutagenic activity of some phenanthroisoquinolines in Salmonella typhimurium.
Tanga MJ; Reist EJ
Mutat Res; 1988 Oct; 206(2):235-8. PubMed ID: 3050503
[TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of 7H-dibenzo[c,g]carbazole and metabolites in Salmonella typhimurium.
Schoeny R; Warshawsky D
Mutat Res; 1987 Aug; 188(4):275-86. PubMed ID: 3302697
[TBL] [Abstract][Full Text] [Related]
16. Structures of mutagens produced by the co-mutagen norharman with o- and m-toluidine isomers.
Hada N; Totsuka Y; Enya T; Tsurumaki K; Nakazawa M; Kawahara N; Murakami Y; Yokoyama Y; Sugimura T; Wakabayashi K
Mutat Res; 2001 Jun; 493(1-2):115-26. PubMed ID: 11516721
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of N-acetylbenzidine and N,N'-diacetylbenzidine to mutagens, using isolated hepatocytes and the 9000 X g liver supernatant from rat, hamster and guinea pig.
Neis JM; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1985 Sep; 151(2):195-200. PubMed ID: 3897847
[TBL] [Abstract][Full Text] [Related]
18. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9.
Suzuki J; Kobayashi Y; Monden S; Suzuki S
Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827
[TBL] [Abstract][Full Text] [Related]
19. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
Gatehouse D; Wedd DJ
Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in the deacetylation of O-glucosides of N-hydroxy-N-arylacylamides by mammalian liver microsomes.
Yoshioka T; Tatsunami R; Ohno H; Uematsu T
Chem Biol Interact; 2001 Jul; 137(1):25-42. PubMed ID: 11518562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
